Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Mbio|March 27, 2014
A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variantSudhakar Agnihothram, Boyd L Yount, Eric F Donaldson, et al.
Influenza and Other Respiratory Viruses|September 17, 2013
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010, William K Ampofo, Norman Baylor, et al.
Lancet (London, England)|May 27, 2014
London 2012 Olympic and Paralympic Games: public health surveillance and epidemiologyBrian McCloskey, Tina Endericks, Mike Catchpole, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 21, 2025
Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade KFreja Cm Kirsebom, Catherine Thompson, Tiina Talts, et al.
The Lancet. Infectious Diseases|October 30, 2025
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control studyRebecca Symes, Heather J Whitaker, Shazaad Ahmad, et al.
Influenza and Other Respiratory Viruses|August 9, 2011
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010, William K Ampofo, Norman Baylor, et al.
The Lancet. Microbe|October 5, 2021
The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilitiesDinesh Aggarwal, Richard Myers, William L Hamilton, et al.
Microbiology Spectrum|March 14, 2024
Rapid emergence of transmissible SARS-CoV-2 variants in mild community casesMichael A Crone, Seran Hakki, Joe Fenn, et al.
The Lancet. Infectious Diseases|May 19, 2020
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studySimon de Lusignan, Jienchi Dorward, Ana Correa, et al.
BMJ Open|June 29, 2022
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocolSarah Wallace, Victoria Hall, Andre Charlett, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Mbio|March 27, 2014
A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variantSudhakar Agnihothram, Boyd L Yount, Eric F Donaldson, et al.
Influenza and Other Respiratory Viruses|September 17, 2013
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010, William K Ampofo, Norman Baylor, et al.
Lancet (London, England)|May 27, 2014
London 2012 Olympic and Paralympic Games: public health surveillance and epidemiologyBrian McCloskey, Tina Endericks, Mike Catchpole, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 21, 2025
Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade KFreja Cm Kirsebom, Catherine Thompson, Tiina Talts, et al.
The Lancet. Infectious Diseases|October 30, 2025
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control studyRebecca Symes, Heather J Whitaker, Shazaad Ahmad, et al.
Influenza and Other Respiratory Viruses|August 9, 2011
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010, William K Ampofo, Norman Baylor, et al.
The Lancet. Microbe|October 5, 2021
The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilitiesDinesh Aggarwal, Richard Myers, William L Hamilton, et al.
Microbiology Spectrum|March 14, 2024
Rapid emergence of transmissible SARS-CoV-2 variants in mild community casesMichael A Crone, Seran Hakki, Joe Fenn, et al.
The Lancet. Infectious Diseases|May 19, 2020
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studySimon de Lusignan, Jienchi Dorward, Ana Correa, et al.
BMJ Open|June 29, 2022
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocolSarah Wallace, Victoria Hall, Andre Charlett, et al.
Pageof 27